Literature DB >> 6874372

Characterization and properties of Hb York (beta 146 His leads to Pro).

H Kosugi, A S Weinstein, K Kikugawa, T Asakura, W A Schroeder.   

Abstract

A second case of Hb York (beta 146 His leads to Pro), was discovered in a patient with polycythemia. The oxygen equilibrium curves (OEC) of red cell suspensions in a buffer (pH 7.4) at 37 degrees C revealed a biphasic curve with a P50 of only 12.5 mm Hg (normal value: 26.5 +/- 1.0 mm Hg). The purified Hb York had an extremely high affinity for oxygen with diminished cooperativity and decreased Bohr effect. The oxygen affinity was significantly reduced by inositol hexaphosphate. Molecular stability studies by mechanical shaking of various liganded forms of Hb York revealed stabilities between those of Hb A and Hb S. Isolated beta Y-subunits were more unstable than beta A-subunits at every pH examined. Hb York was 1.4 times more unstable than Hb A in 18.9% isopropanol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874372     DOI: 10.3109/03630268309048651

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  A case of hemoglobin Hiroshima (β146 histidine to aspartic acid) with compensatory erythremia and undetectable HbA₁c.

Authors:  Hisakazu Nishimori; Keiko Harano; Hideho Wada; Satoshi Takano; Shinji Fukuda; Yukihito Takehara; Hiroshi Matsumoto; Isao Kumagai; Mitsune Tanimoto; Sho Takeda
Journal:  Int J Hematol       Date:  2012-04-08       Impact factor: 2.490

2.  Lack of conventional oxygen-linked proton and anion binding sites does not impair allosteric regulation of oxygen binding in dwarf caiman hemoglobin.

Authors:  Roy E Weber; Angela Fago; Hans Malte; Jay F Storz; Thomas A Gorr
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-05-29       Impact factor: 3.619

3.  Anaesthesia in a patient with subarachanoidal haemorrhage and high oxygen affinity haemoglobinopathy (HB york): case report.

Authors:  Enrico Monaca; Tobias Jüttner; Norbert Gattermann; Michael Winterhalter
Journal:  BMC Anesthesiol       Date:  2012-08-08       Impact factor: 2.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.